There is provided the use of an isolated polypeptide for the manufacture of a medicament for treating hepatitis B or C, wherein said polypeptide comprises an amino acid sequence having at least 80% identity with amino acid residues 22 to 205 of SEQ ID NO: 2 or amino acid residues 22 to 205 of SEQ ID NO: 7.
申请公布号
EP1501936(A2)
申请公布日期
2005.02.02
申请号
EP20020764322
申请日期
2002.04.19
申请人
ZYMOGENETICS, INC.
发明人
SHEPPARD, PAUL, O.;FOX, BRAIN, A.;KLUCHER, KEVIN, M.;TAFT, DAVID W.;KINDSVOGEL, WAYNE, R.
